Press Reporting
Contact
Birgitta von Glass
BayOConnect Project Management
BayOConnect 2025: Bavaria showed great biomedical innovation potential in dynamic times
Official press release
Discussed the future of global biotechnology in dynamic times (fltr): Kevin Peters, Managing Director, MSD Sharp & Dohme, Han Steutel, President Verband Forschender Arzneimittelhersteller e.V. (vfa), Dr. Laura Matz, Chief Science and Technology Officer, Merck KGaA, Prof. Dr. Francis de Véricourt, Institute for Deep Tech Innovation (DEEP) at the European School of Management and Technology Berlin, and Prof. Dr. Ralf Huss, Managing Director BioM. Copyright: © BioM / Bert Willer
Around 350 players from the Bavarian, German and international biotechnology industry responded to the call of the biotech cluster development organization BioM to attend the 2nd edition of the biotechnology conference “BayOConnect - Forum for Biotech & LifeScience” in Munich. On July 1 and 2, big players, SMEs, start-ups, science, pharmaceuticals, politics and investors met to exchange ideas. The industry discussed the changing framework conditions for innovation in dynamic times. Start-ups presented new ideas on innovative gene therapy, RNA targeting and non-invasive cancer diagnostics, among other things. The conference concluded with the ceremonial presentation of the m4 Award, endowed with 2.5 million euros, to 5 Bavarian teams for outstanding biomedical research. ... [read more]